Search

NGX267

It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms and slow disease progression.

Rhizopus stolonifer

Rhizopus stolonifer is a fungus which can provoke allergic reactions. Rhizopus stolonifer extract is used in allergenic testing.

Brentuximab

SGN-30 received orphan drug designation from the FDA in July 2003 for Hodgkin lymphoma and in February 2004 for T-cell lymphomas. … It is available commercially as the monoclonal antibody portion of the antibody-drug conjugate [brentuximab vedotin].

Vandetanib

On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced, or metastatic medullary thyroid cancer in adult patients.

Capmatinib

Manufactured by Novartis and marketed under the brand name Tabrecta, capmatinib was granted accelerated approval by the FDA on May 6, 2020,[L13380] for the treatment of NSCLC in patients whose tumors have … a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping.

Virginiamycin M1

It is produced by Streptomyces graminofaciens and other bacteria.

Didecyldimethylammonium

Pemigatinib

This malignancy accounts for 15% to 20% of primary hepatobiliary malignancies, which account for 13% of overall cancer-related global mortality. … Pemigatinib is marketed under the brand name Pemazyre, and it is available as oral tablets.[L13050]

Thymidine

[A274683] While it lacks significant anti-tumor activity on its own,[A274688] it has been extensively investigated for nearly a decade as a biochemical modulator to enhance the efficacy and reduce the

Riltozinameran

[L43917] As of November 2022, it is the primary circulating variant of concern according to the World Health Organization. … [L43922] It tends to cause less severe disease but is significantly more virulent than both the original virus and earlier variants (e.g. Delta).